Date Filed | Type | Description |
06/09/2023 |
4
| O'Neill Julie (Director) has filed a Form 4 on HOOKIPA Pharma Inc.
Txns:
| Granted 26,000 options to buy
@ $1.01, valued at
$26.3k
|
|
07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/11/2021 |
3
| O'Neill Julie (Director) has filed a Form 3 on DBV Technologies S.A. |
10/23/2020 |
4
| O'Neill Julie (Director) has filed a Form 4 on HOOKIPA Pharma Inc.
Txns:
| Granted 4,969 shares
@ $0 |
|
06/19/2020 |
4
| O'Neill Julie (Director) has filed a Form 4 on HOOKIPA Pharma Inc.
Txns:
| Granted 9,600 options to buy
@ $11.45, valued at
$109.9k
|
|
01/03/2020 |
4
| O'Neill Julie (Director) has filed a Form 4 on HOOKIPA Pharma Inc.
Txns:
| Granted 9,600 options to buy
@ $9.96, valued at
$95.6k
|
|
04/24/2019 |
4
| O'Neill Julie (Director) has filed a Form 4 on HOOKIPA Pharma Inc.
Txns:
| Granted 6,924 options to buy
@ $14, valued at
$96.9k
|
|
04/17/2019 |
3
| O'Neill Julie (Director) has filed a Form 3 on HOOKIPA Pharma Inc. |
03/02/2018 |
4
| O'Neill Julie (EVP. Global Operations) has filed a Form 4 on ALEXION PHARMACEUTICALS INC
Txns:
| Granted 8,940 shares
@ $0 |
|
03/01/2018 |
4
| O'Neill Julie (EVP. Global Operations) has filed a Form 4 on ALEXION PHARMACEUTICALS INC
Txns:
| Sold 939 shares
@ $120.72, valued at
$113.4k
Sold 686 shares
@ $118.61, valued at
$81.4k
|
|
02/08/2018 |
4
| O'Neill Julie (EVP. Global Operations) has filed a Form 4 on ALEXION PHARMACEUTICALS INC
Txns:
| Granted 21,489 shares
@ $0 Granted 7,500 shares
@ $0 Sold 4,787 shares
@ $116.31, valued at
$556.8k
|
|
02/07/2018 |
4
| O'Neill Julie (EVP. Global Operations) has filed a Form 4 on ALEXION PHARMACEUTICALS INC
Txns:
| Sold 2,119 shares
@ $117.26, valued at
$248.5k
|
|
09/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/06/2017 |
4
| O'Neill Julie (EVP. Global Operations) has filed a Form 4 on ALEXION PHARMACEUTICALS INC
Txns:
| Sold 651 shares
@ $133.8, valued at
$87.1k
|
|
03/01/2017 |
4
| O'Neill Julie (EVP. Global Operations) has filed a Form 4 on ALEXION PHARMACEUTICALS INC
Txns:
| Sold 910 shares
@ $131.2, valued at
$119.4k
Sold 664 shares
@ $131.7, valued at
$87.4k
Granted 7,500 shares
@ $0 Granted 14,800 options to buy
@ $131.25, valued at
$1.9M
|
|
02/08/2017 |
4
| O'Neill Julie (EVP. Global Operations) has filed a Form 4 on ALEXION PHARMACEUTICALS INC
Txns:
| Sold 2,795 shares
@ $125.69, valued at
$351.3k
|
|
09/02/2016 |
4
| O'Neill Julie (EVP. Global Operations) has filed a Form 4 on ALEXION PHARMACEUTICALS INC
Txns:
| Sold 650 shares
@ $126.29, valued at
$82.1k
|
|
03/04/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/01/2016 |
4
| O'Neill Julie (EVP. Global Operations) has filed a Form 4 on ALEXION PHARMACEUTICALS INC
Txns:
| Granted 7,000 shares
@ $0 Sold 663 shares
@ $138.91, valued at
$92.1k
Granted 31,000 options to buy
@ $140.16, valued at
$4.3M
|
|
02/08/2016 |
4
| O'Neill Julie (EVP. Global Operations) has filed a Form 4 on ALEXION PHARMACEUTICALS INC
Txns:
| Granted 11,763 shares
@ $0 Sold 348 shares
@ $145.55, valued at
$50.7k
Sold 352 shares
@ $144.53, valued at
$50.9k
Sold 351 shares
@ $143.46, valued at
$50.4k
Sold 499 shares
@ $142.33, valued at
$71k
Sold 530 shares
@ $141.54, valued at
$75k
Sold 23 shares
@ $139.75, valued at
$3.2k
Sold 755 shares
@ $138.02, valued at
$104.2k
|
|